Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Jost

Showing results (291-300 of 384) with videos related to

Pageof 39
Sort By:
Journal of Neurology|January 29, 2005
Is levodopa toxic?Thomas Müller, Harald Hefter, Roland Hueber, et al.
Klinische Monatsblatter Fur Augenheilkunde|March 1, 1995
[Disorders of eye movement in amyotrophic lateral sclerosis--report of 2 patients]A Palmowski, W H Jost, J Osterhage, et al.
Journal of Medical Economics|August 27, 2014
Assessing the burden of illness from cervical dystonia using the Toronto Western Spasmodic Torticollis Rating Scale scores and health utility: a meta-analysis of baseline patient-level clinical trial dataMin-Hua Jen, Hannah Kurth, Ike Iheanacho, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|August 11, 2020
Tremor in Idiopathic Cervical Dystonia - Possible Implications for Botulinum Toxin Treatment Considering the Col-Cap ClassificationSanjay Pandey, Alexandre Kreisler, Artur Drużdż, et al.
Journal of the Neurological Sciences|February 17, 2019
Effectiveness of botulinum neurotoxin type A injections in naïve and previously-treated patients suffering from Torti- or Laterocollis or -caput: Results from a German-Austrian open-label prospective post-marketing surveillance studyW H Jost, A Schramm, M Müngersdorf, et al.
Fortschritte Der Neurologie-Psychiatrie|August 10, 2010
[Depression in Parkinson's disease--Part 2: Therapy and management]A Storch, C Schneider, G Ebersbach, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|September 28, 2016
Poster 281 The Adult Spasticity International Registry (ASPIRE Study): Baseline Demographics and Clinical Characteristics of Patients Treated for SpasticityGerard E Francisco, Daniel Bandari, Ganesh Bavikatte, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 30, 2025
Far from being the end of the road: taking a closer look at neuropalliative care in Parkinson's diseaseManon Auffret, Fran Borovecki, Beatrice Heim, et al.
Applied and Environmental Microbiology|May 26, 2001
Species-specific, nested PCR-restriction fragment length polymorphism detection of single Cryptosporidium parvum oocystsG D Sturbaum, C Reed, P J Hoover, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 25, 2023
Clinical benefit of MAO-B and COMT inhibition in Parkinson's disease: practical considerationsMartin Regensburger, Chi Wang Ip, Zacharias Kohl, et al.
Pageof 39

Showing results (291-300 of 384) with videos related to

Sort By:
Pageof 39
Journal of Neurology|January 29, 2005
Is levodopa toxic?Thomas Müller, Harald Hefter, Roland Hueber, et al.
Klinische Monatsblatter Fur Augenheilkunde|March 1, 1995
[Disorders of eye movement in amyotrophic lateral sclerosis--report of 2 patients]A Palmowski, W H Jost, J Osterhage, et al.
Journal of Medical Economics|August 27, 2014
Assessing the burden of illness from cervical dystonia using the Toronto Western Spasmodic Torticollis Rating Scale scores and health utility: a meta-analysis of baseline patient-level clinical trial dataMin-Hua Jen, Hannah Kurth, Ike Iheanacho, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|August 11, 2020
Tremor in Idiopathic Cervical Dystonia - Possible Implications for Botulinum Toxin Treatment Considering the Col-Cap ClassificationSanjay Pandey, Alexandre Kreisler, Artur Drużdż, et al.
Journal of the Neurological Sciences|February 17, 2019
Effectiveness of botulinum neurotoxin type A injections in naïve and previously-treated patients suffering from Torti- or Laterocollis or -caput: Results from a German-Austrian open-label prospective post-marketing surveillance studyW H Jost, A Schramm, M Müngersdorf, et al.
Fortschritte Der Neurologie-Psychiatrie|August 10, 2010
[Depression in Parkinson's disease--Part 2: Therapy and management]A Storch, C Schneider, G Ebersbach, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|September 28, 2016
Poster 281 The Adult Spasticity International Registry (ASPIRE Study): Baseline Demographics and Clinical Characteristics of Patients Treated for SpasticityGerard E Francisco, Daniel Bandari, Ganesh Bavikatte, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 30, 2025
Far from being the end of the road: taking a closer look at neuropalliative care in Parkinson's diseaseManon Auffret, Fran Borovecki, Beatrice Heim, et al.
Applied and Environmental Microbiology|May 26, 2001
Species-specific, nested PCR-restriction fragment length polymorphism detection of single Cryptosporidium parvum oocystsG D Sturbaum, C Reed, P J Hoover, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 25, 2023
Clinical benefit of MAO-B and COMT inhibition in Parkinson's disease: practical considerationsMartin Regensburger, Chi Wang Ip, Zacharias Kohl, et al.
Pageof 39